We next evaluated the effects of YE6144 on innate immune responses mediated by TLR7 and TLR9, which are known to participate in the SLE pathogenesis via the recognition of nucleic acid-containing immune complexes39,40. This evidence concerns the gene TLR9 and systemic lupus erythematosus.